Advances in Transcatheter Aortic Valve Replacement.

about

Resource utilization and procedure-related costs associated with transfemoral transcatheter aortic valve replacement.

P2860

Q38917800-37451FA8-E6DF-4BA7-8031-8C5C17B03DB2

P2860

Advances in Transcatheter Aortic Valve Replacement.

Item

http://www.wikidata.org/entity/Q36844238

description

2016 nî lūn-bûn

@nan

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

name

Advances in Transcatheter Aortic Valve Replacement.

@en

type

Item

label

Advances in Transcatheter Aortic Valve Replacement.

@en

prefLabel

Advances in Transcatheter Aortic Valve Replacement.

@en

P1476

Advances in Transcatheter Aortic Valve Replacement.

@en

P2093

Michael J Reardon

http://www.w3.org/2001/XMLSchema#string

Neal S Kleiman

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the

Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.

Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial.

Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial.

2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery.

Treatment of Symptomatic Severe Aortic Stenosis With a Novel Resheathable Supra-Annular Self-Expanding Transcatheter Aortic Valve System.

2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement.

5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.

P304

33-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14797/MDCJ-12-1-33

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27127560

http://www.w3.org/2001/XMLSchema#string

P921

aorta

P932

4847966

http://www.w3.org/2001/XMLSchema#string

Advances in Transcatheter Aortic Valve Replacement.

about

P2860

P2860

Advances in Transcatheter Aortic Valve Replacement.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932